111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow
SHANGHAI, May 26, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2022, before the U.S. market opens on Thursday, June 16, 2022.
111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, June 16, 2022 (7:30 PM Beijing Time on the same day).
Details for the conference call are as follows:
Conference Topic: 111, Inc. First Quarter 2022 Earnings Conference Call
Registration Link: http://apac.directeventreg.com/registration/event/5728866
All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will receive a set of participant dial-in numbers, the Direct Event passcode, and a unique Registration ID, which can be used to join the conference call.
Please dial in 15 minutes before the call is scheduled to begin and provide the Direct Event passcode and unique Registration ID you have received upon registering to join the call.
A telephone replay of the call will be available after the conclusion of the conference call until June 24, 2022 09:59 ET
United States: +18554525696
International: +61 2 8199 0299
Conference ID: 5728866
A live and archived webcast of the conference call will be available on the website at https://edge.media-server.com/mmc/p/a246si8g.
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine Marketplace, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.
For more information on 111, please visit: http://ir.111.com.cn/.
For further information: For more information, please contact: 111, Inc., Investor Relations, Email: email@example.com; 111, Inc., Media Relations, Email: firstname.lastname@example.org, Phone: +86-021-2053 6666 (China)
View original content:https://www.prnewswire.com/news-releases/111-to-announce-first-quarter-2022-unaudited-financial-results-on-june-16-2022---conference-call-to-follow-301555707.html
Source: 111, Inc. Related Stocks: NASDAQ:YI
- IT Tech Packaging, Inc. Announces Second Quarter 2022 Unaudited Financial Results
- Launched to immediate global acclaim via Livestream: Absen's pioneering KLCOB Micro LED product series
- SEMI Applauds President Biden's Signing of CHIPS and Science Act of 2022
- OpenSpace Expands Strategic Capital with an Additional US$9M in Funding, Bringing Series D Total to US$111M
- Invitation to presentation of Q2 2022
Vietlott Energy Lottery 6/55 August 9: Discover the proprietor of an enormous Jackpot of 40 billion VND?
Tamagotchi children: Elevating ‘digital infants’ in metaverse
BM PLASCO honored in Forbes Vietnam's Top 50 best listed firms
Clearing the way to legal support for BNPL services
Long way to go for Vietnamese durian